• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依据新的质量指标对系统性红斑狼疮患者进行骨质疏松症和心血管疾病护理

Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators.

作者信息

Demas Kristina L, Keenan Brendan T, Solomon Daniel H, Yazdany Jinoos, Costenbader Karen H

机构信息

George Washington School of Medicine, Washington, DC, USA.

出版信息

Semin Arthritis Rheum. 2010 Dec;40(3):193-200. doi: 10.1016/j.semarthrit.2010.01.001. Epub 2010 Apr 8.

DOI:10.1016/j.semarthrit.2010.01.001
PMID:20378155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2932869/
Abstract

OBJECTIVES

Quality indicators (QIs) for the assessment of care of patients with systemic lupus erythematosus (SLE) have been proposed. We evaluated care according to these proposed QIs for osteoporosis and cardiovascular disease (CVD) in patients with SLE in our rheumatology practice.

METHODS

We selected 200 patients with SLE according to American College of Rheumatology Criteria and ≥2 visits to our practice in 2007 to 2008. We performed a structured medical record review and collected demographics, SLE and past medical history, medications, laboratories and data concerning osteoporosis, and CVD management. We employed univariable analyses and multivariable regression analyses to test for factors associated with care meeting the proposed QIs.

RESULTS

Ninety-four percent of patients were female and 64% were white. Mean age was 46.3 years and mean lupus duration was 15.3 years. Twenty-nine percent were taking ≥7.5 mg prednisone per day for ≥3 months. The proportions of patients for whom care met the proposed QIs were as follows: 59% for bone mineral density testing, 62% for calcium and vitamin D supplementation, and 86% for antiresorptive or anabolic osteoporosis medications. Only 3% had 5 cardiac risk factors assessed within the year and 26% had 4 cardiac risk factors assessed annually. Smoking, fasting lipid panels, and diabetes mellitus were rarely assessed annually. Having a primary care physician within our health care network increased care meeting QIs.

CONCLUSIONS

Care according to newly proposed QIs for osteoporosis and CVD was suboptimal in our academic center. To standardize and improve care of patients with SLE, we suggest specific changes to the proposed QIs.

摘要

目的

已提出用于评估系统性红斑狼疮(SLE)患者护理情况的质量指标(QIs)。我们根据这些针对骨质疏松症和心血管疾病(CVD)的拟议QIs,在我们的风湿病科实践中评估了SLE患者的护理情况。

方法

我们根据美国风湿病学会标准,选取了200例SLE患者,这些患者在2007年至2008年期间到我们科室就诊≥2次。我们进行了结构化病历审查,并收集了人口统计学资料、SLE及既往病史、用药情况、实验室检查结果以及有关骨质疏松症和CVD管理的数据。我们采用单变量分析和多变量回归分析来检验与符合拟议QIs的护理相关的因素。

结果

94%的患者为女性,64%为白人。平均年龄为46.3岁,平均狼疮病程为15.3年。29%的患者每天服用≥7.5毫克泼尼松≥3个月。护理符合拟议QIs的患者比例如下:骨密度检测为59%,补充钙和维生素D为62%,抗吸收或促合成骨质疏松药物治疗为86%。一年内仅3%的患者评估了5项心血管危险因素,每年有26%的患者评估了4项心血管危险因素。吸烟、空腹血脂检查和糖尿病很少每年进行评估。在我们的医疗保健网络中有初级保健医生可提高符合QIs的护理水平。

结论

在我们的学术中心,根据新提出的骨质疏松症和CVD的QIs进行的护理并不理想。为了规范和改善SLE患者的护理,我们建议对拟议的QIs进行具体修改。

相似文献

1
Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators.依据新的质量指标对系统性红斑狼疮患者进行骨质疏松症和心血管疾病护理
Semin Arthritis Rheum. 2010 Dec;40(3):193-200. doi: 10.1016/j.semarthrit.2010.01.001. Epub 2010 Apr 8.
2
Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators.系统性红斑狼疮中的骨质疏松症筛查、预防和治疗:系统性红斑狼疮质量指标的应用。
Arthritis Care Res (Hoboken). 2010 Jul;62(7):993-1001. doi: 10.1002/acr.20150.
3
Vitamin D and bisphosphonate therapy in systemic lupus erythematosus patients who receive glucocorticoids: are we offering the best care?维生素 D 和双膦酸盐治疗接受糖皮质激素治疗的系统性红斑狼疮患者:我们提供的是最佳护理吗?
Lupus. 2020 Mar;29(3):263-272. doi: 10.1177/0961203320903086. Epub 2020 Jan 29.
4
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.基于 2019 年 EULAR 建议的系统性红斑狼疮质量指标:在 220 例患者队列中的制定和初步验证。
Ann Rheum Dis. 2021 Sep;80(9):1175-1182. doi: 10.1136/annrheumdis-2021-220438. Epub 2021 Jun 23.
5
Association of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional study.临床环境与系统性红斑狼疮质量指标表现的关联:一项横断面研究。
Arthritis Res Ther. 2022 Jun 22;24(1):150. doi: 10.1186/s13075-022-02823-9.
6
Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic.系统性红斑狼疮生殖健康护理质量指标在城市公立风湿病诊所的应用及可行性
Lupus. 2015 Feb;24(2):203-9. doi: 10.1177/0961203314552832. Epub 2014 Sep 29.
7
Real-world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damage.真实世界中系统性红斑狼疮患者的治疗模式:与合并症和损伤的关联。
Lupus Sci Med. 2024 Sep 24;11(2):e001266. doi: 10.1136/lupus-2024-001266.
8
High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan.高双膦酸盐治疗率与系统性红斑狼疮患者非典型股骨骨折的患病率:日本单中心回顾性研究。
Rheumatol Int. 2019 Oct;39(10):1803-1810. doi: 10.1007/s00296-019-04407-4. Epub 2019 Aug 5.
9
Initial Benchmarking of the Quality of Medical Care in Childhood-Onset Systemic Lupus Erythematosus.儿童期起病的系统性红斑狼疮医疗质量的初步基准评估
Arthritis Care Res (Hoboken). 2016 Feb;68(2):179-86. doi: 10.1002/acr.22666.
10
Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.系统性红斑狼疮患者骨密度的 6 年随访研究。
Osteoporos Int. 2013 Jun;24(6):1827-33. doi: 10.1007/s00198-012-2157-9. Epub 2012 Oct 3.

引用本文的文献

1
Implementing a Staff-Led Smoking Cessation Intervention in a Diverse Safety-Net Rheumatology Clinic: A Pre-Post Scalability Study in a Low-Resource Setting.在一个多元化的保障网风湿病诊所实施员工主导的戒烟干预措施:在资源匮乏环境下的预-后可扩展性研究。
Arthritis Care Res (Hoboken). 2024 Sep;76(9):1342-1350. doi: 10.1002/acr.25349. Epub 2024 Jun 3.
2
Utilization of preventive services in a systemic lupus erythematosus population-based cohort: a Lupus Midwest Network (LUMEN) study.基于系统性红斑狼疮人群的预防性服务利用:狼疮中西部网络(LUMEN)研究。
Arthritis Res Ther. 2022 Sep 1;24(1):211. doi: 10.1186/s13075-022-02878-8.
3
Electronic health record data use in the assessment of quality indicators for glucocorticoid osteoporosis screening in systemic lupus erythematosus.电子健康记录数据在系统性红斑狼疮糖皮质激素性骨质疏松症筛查质量指标评估中的应用。
Lupus. 2022 Oct;31(12):1516-1522. doi: 10.1177/09612033221116726. Epub 2022 Jul 20.
4
Association of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional study.临床环境与系统性红斑狼疮质量指标表现的关联:一项横断面研究。
Arthritis Res Ther. 2022 Jun 22;24(1):150. doi: 10.1186/s13075-022-02823-9.
5
A Retrospective Analysis of Longitudinal Changes in Bone Mineral Density in Women with Systemic Lupus Erythematosus.系统性红斑狼疮女性骨密度纵向变化的回顾性分析。
Calcif Tissue Int. 2021 Oct;109(4):363-371. doi: 10.1007/s00223-021-00845-0. Epub 2021 Apr 17.
6
Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure.系统性红斑狼疮患者及糖皮质激素暴露者中骨密度检测的低流行率。
Lupus. 2021 Mar;30(3):403-411. doi: 10.1177/0961203320979735. Epub 2020 Dec 13.
7
Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus.利用质量指标识别系统性红斑狼疮医疗保健中的差异。
Rheum Dis Clin North Am. 2020 Nov;46(4):623-638. doi: 10.1016/j.rdc.2020.07.003. Epub 2020 Sep 9.
8
Quality of care predicts outcome in systemic lupus erythematosus: a cross-sectional analysis of a German long-term study (LuLa cohort).护理质量预测系统性红斑狼疮的结局:一项德国长期研究(LuLa 队列)的横断面分析。
Lupus. 2020 Feb;29(2):136-143. doi: 10.1177/0961203319896626.
9
Quality of Care for the Screening, Diagnosis, and Management of Lupus Nephritis Across Multiple Health Care Settings.跨多种医疗环境的狼疮性肾炎筛查、诊断和管理的医疗质量。
Arthritis Care Res (Hoboken). 2020 Jul;72(7):888-896. doi: 10.1002/acr.23915. Epub 2020 May 14.
10
Lipid Testing and Statin Prescriptions Among Medicaid Recipients With Systemic Lupus Erythematosus or Diabetes Mellitus and the General Medicaid Population.血脂检测和他汀类药物处方在患有系统性红斑狼疮或糖尿病的医疗补助受助人及一般医疗补助人群中的应用。
Arthritis Care Res (Hoboken). 2019 Jan;71(1):104-115. doi: 10.1002/acr.23574.

本文引用的文献

1
The JUPITER trial: How will it change clinical practice?JUPITER试验:它将如何改变临床实践?
Rev Cardiovasc Med. 2009 Spring;10(2):91-6.
2
A quality indicator set for systemic lupus erythematosus.一套针对系统性红斑狼疮的质量指标集。
Arthritis Rheum. 2009 Mar 15;61(3):370-7. doi: 10.1002/art.24356.
3
Does treatment with bisphosphonates endanger the human pregnancy?双膦酸盐治疗会危及人类妊娠吗?
J Obstet Gynaecol Can. 2008 Dec;30(12):1146-1148. doi: 10.1016/S1701-2163(16)34026-9.
4
Quality of care in the rheumatic diseases: current status and future directions.风湿性疾病的医疗质量:现状与未来方向
Curr Opin Rheumatol. 2008 Mar;20(2):159-66. doi: 10.1097/BOR.0b013e3282f50ec4.
5
Disease-specific quality indicators, guidelines, and outcome measures in systemic lupus erythematosus (SLE).系统性红斑狼疮(SLE)的疾病特异性质量指标、指南及结局指标
Clin Exp Rheumatol. 2007 Nov-Dec;25(6 Suppl 47):107-13.
6
Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.系统性红斑狼疮中的早发性动脉粥样硬化性心血管疾病
Arthritis Rheum. 2007 May;56(5):1384-96. doi: 10.1002/art.22568.
7
Guidelines and performance measures for diabetes.糖尿病指南与绩效指标
Am J Manag Care. 2007 Apr;13 Suppl 2:S41-6.
8
Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions.骨质疏松症的药物使用模式:对指南、治疗率及质量改进干预措施的评估
Mayo Clin Proc. 2005 Feb;80(2):194-202. doi: 10.4065/80.2.194.
9
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.美国国家高血压预防、检测、评估与治疗联合委员会第七次报告:JNC 7报告。
JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560. Epub 2003 May 14.
10
The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research.自我管理的共病问卷:一种用于临床和卫生服务研究中评估共病的新方法。
Arthritis Rheum. 2003 Apr 15;49(2):156-63. doi: 10.1002/art.10993.